The Influence of the Estrous Cycle on Neuropeptide S Receptor-Mediated Behaviors

被引:1
|
作者
Costa, Paula Carvalho [1 ]
Salinas, Brisa [1 ]
Wojciechowski, Alaina [1 ]
Wood, Susan K. [2 ,3 ]
Runyon, Scott [4 ]
Clark, Stewart D. [1 ]
机构
[1] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY USA
[2] Univ South Carolina, Sch Med, Dept Pharmacol Physiol & Neurosci, Columbia, SC USA
[3] Dorn VA Med Ctr, Columbia, SC USA
[4] Ctr Drug Discovery, Res Triangle Inst, Res Triangle Pk, NC USA
基金
美国国家卫生研究院;
关键词
GENE NPSR1; VARIANT; STRESS; ASSOCIATION; ANXIETY; MEMORY; BRAIN; SCHIZOPHRENIA; POLYMORPHISM; ASN(107)ILE;
D O I
10.1124/jpet.124.002415
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The neuropeptide S receptor (NPSR) has been identified as a potential therapeutic target for anxiety and post-traumatic stress disorder. Central administration of neuropeptide S (NPS) in male mice produces anxiolytic-like effects, hyperlocomotion, and memory enhancement. Currently, the literature is limited in the number of studies investigating the effects of NPS in female test subjects despite females facing a higher prevalence of anxiety-related pathology, as well as greater risk for adverse effects while taking psychoactive drugs. Moreover, no previous studies have considered the influence of estrous cycle on the effects of NPS. The present study investigates whether NPS-mediated behavioral phenotypes seen in males translate to females, and whether they are affected by estrous cycle stage. Female C57BL/6NCr mice were intracerebroventricularly cannulated and underwent behavioral paradigms to test locomotion, anxiety, and memory. Estrous cycle stage was determined through examination of vaginal cytology. Our results provide evidence that NPS-mediated behaviors are influenced by the estrous cycle. Administration of NPS decreased anxiety-like behaviors more robustly when the female mice were in high estrogen stages of the estrous cycle. Therefore, the desired anxiolytic-like effects of targeting the NPSR are intact in female mice. However, these effects may to be influenced by the stage of the estrous cycle. The NPSR remains a strong potential drug target for new anxiolytic compounds and based on our initial observations further studies exploring the interaction of estrous cycle and the NPS system are warranted. SIGNIFICANCE STATEMENT The neuropeptide S (NPS) receptor has been identified as a potential target for treating anxiety, a condition that is most prevalent in females. Therefore, the potential interaction of estrous cycle with the NPS system described in the present study is an important first step in understanding the function of the NPS system in females.
引用
收藏
页码:460 / 471
页数:12
相关论文
共 50 条
  • [1] Effects of the Mouse Estrous Cycle on Neuropeptide S Receptor-Mediated Behaviors
    Costa, Paula
    Runyon, Scott
    Clark, Stewart
    FASEB JOURNAL, 2022, 36
  • [2] Estrous Cycle Regulation of Extrasynaptic δ-Containing GABAA Receptor-Mediated Tonic Inhibition and Limbic Epileptogenesis
    Wu, Xin
    Gangisetty, Omkaram
    Carver, Chase Matthew
    Reddy, Doodipala Samba
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 346 (01): : 146 - 160
  • [3] RECEPTOR-MEDIATED REGULATION OF NEUROPEPTIDE TRANSCRIPTION VIA CAMP
    BIRNBERG, NC
    COMB, MJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 182 - 182
  • [4] RECEPTOR-MEDIATED REGULATION OF NEUROPEPTIDE GENE-EXPRESSION IN ASTROCYTES
    SCHWARTZ, JP
    NISHIYAMA, N
    WILSON, D
    TANIWAKI, T
    GLIA, 1994, 11 (02) : 185 - 190
  • [5] Minimal influence of estrous cycle on studies of female mouse behaviors
    Zeng, Pei-Yun
    Tsai, Ya-Hsuan
    Lee, Chih-Lin
    Ma, Yu-Kai
    Kuo, Tsung-Han
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2023, 16
  • [6] A comparative study on the influence of estrous cycle on cognitive and coping behaviors in rats
    Emine Babar
    Enver Melik
    Kubra Akillioglu
    Sayad Kocahan
    Annals of General Psychiatry, 7 (Suppl 1)
  • [7] Signaling underlying kappa opioid receptor-mediated behaviors in rodents
    Liu-Chen, Lee-Yuan
    Huang, Peng
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [8] NEUROPEPTIDE-Y INHIBITION OF NICOTINIC RECEPTOR-MEDIATED CHROMAFFIN CELL SECRETION
    HEXUM, TD
    ZHENG, J
    ZHU, J
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 271 (01): : 61 - 66
  • [9] Pharmacological Properties of δ-Opioid Receptor-Mediated Behaviors: Agonist Efficacy and Receptor Reserve
    Dripps, Isaac J.
    Chen, Ruizhuo
    Shafer, Amanda M.
    Livingston, Kathryn E.
    Disney, Alexander
    Husbands, Stephen M.
    Traynor, John R.
    Rice, Kenner C.
    Jutkiewicz, Emily M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2020, 374 (02): : 319 - 330
  • [10] Aberrant receptor-mediated Cushing's syndrome
    Bertagna, X
    Groussin, L
    Luton, JP
    Bertherat, J
    HORMONE RESEARCH, 2003, 59 : 99 - 103